Skip to main content

Medical Devices

By Tom Sullivan | 09:41 am | August 11, 2015
Calico, Google X and Google Ventures, all with significant healthcare focus, will become separate units under Alphabet.
By Henry Powderly | 03:35 pm | July 29, 2015
New York-based investment firm Deerfield Management on Wednesday said it has launched a $550 million healthcare venture capital fund to support companies developing advancements for treating genetic diseases, cancer and orphan diseases, as well as to support tech companies creating new therapeutic devices.
By Anthony Brino | 08:05 am | July 16, 2015
Ambitious diagnostics company will bring its low-cost blood testing to Medicaid patients.
By Henry Powderly | 09:58 am | July 01, 2015
Major cancer centers topped the list with tens of millions in payments and services from pharmaceutical giants.
By Henry Powderly | 04:06 pm | June 30, 2015
Several teaching hospitals raked millions in payments from device and drug manufacturers in 2014, according to new data from the Centers for Medicare and Medicaid Services released Tuesday that showed drug and medical device makers made close to $6.5 billion in payments to healthcare providers in 2014.
By Anthony Brino | 01:46 pm | June 08, 2015
Entrepreneur claims direct-to-consumer laboratory testing and price transparency are an integral piece of health reform and a solution to America's disease and cost problems.
By Anthony Brino | 09:14 am | March 20, 2015
Many startups aimed at bringing hospitals and physicians software and management services to adapt to new Medicare and insurance payment models.
By Henry Powderly | 03:43 pm | March 10, 2015
Lobbyists for the medical device makers handed out nearly $33 million in 2014 to politicians supporting bills to repeal the medical device tax.
By Healthcare Finance Staff | 02:52 pm | March 09, 2015
New developers platform hopes to enhance medical diagnostics and research.
By Anthony Brino | 01:45 pm | March 09, 2015
Theranos technology can take a drop of blood from the finger and screen for a spectrum of conditions and diseases at half the price of Medicare.